Chagas' myocarditis imported into France

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

ESMO open·2026

18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.

Breast cancer research : BCR·2025

Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort.

ESMO open·2025

Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.

Cancer epidemiology·2025

Can an active lifestyle offset the relationship that poor lifestyle behaviours have on frailty?

Archives of gerontology and geriatrics·2024

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.

ESMO open·2024

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Nonlinear driving mechanisms of system adaptability in China's art and cultural tourism industry.

Scientific reports·2026

Spatial proximity to national 5A tourist attractions and corporate environmental governance: Evidence from China.

PloS one·2026

Designing an entrepreneurial model in medical tourism for hospitals in Tehran.

Journal of education and health promotion·2026

Virtual tourism attractiveness: Dimension identification, scale development and validation.

Acta psychologica·2026

Passport Not Required: A Comparison of Plastic Surgery Complications From Domestic and International Medical Tourism.

Annals of plastic surgery·2026

Research on the influencing factors of user engagement in tourism short video from the perspective of configuration.

PloS one·2025

Related Experiment Videos

Chagas' myocarditis imported into France

Related Concept Videos

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.

Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort.

Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.

Can an active lifestyle offset the relationship that poor lifestyle behaviours have on frailty?

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Nonlinear driving mechanisms of system adaptability in China's art and cultural tourism industry.

Spatial proximity to national 5A tourist attractions and corporate environmental governance: Evidence from China.

Designing an entrepreneurial model in medical tourism for hospitals in Tehran.

Virtual tourism attractiveness: Dimension identification, scale development and validation.

Passport Not Required: A Comparison of Plastic Surgery Complications From Domestic and International Medical Tourism.

Research on the influencing factors of user engagement in tourism short video from the perspective of configuration.

Related Experiment Videos

Chagas' myocarditis imported into France

Related Concept Videos

Related Articles